【沛嘉医疗:完成ReachTactile机器人辅助TAVR系统首次人体临床试验】沛嘉医疗公告,公司完成ReachTactile机器人辅助经导管主动脉瓣置换(TAVR)系统首次人体临床试验的首例患者治疗。手术由厦门大学附属心血管病医院的王焱教授及其团队完成,利用ReachTactile™机器人辅助TAVR系统为一名重度主动脉瓣狭窄患者植入TaurusElite®经导管主动脉瓣膜。ReachTactile是公司内部研发的机器人辅助TAVR系统,为TAVR治疗提供创新、高性价比的解决方案。

金融界
06 Apr
沛嘉医疗公告,公司完成ReachTactile机器人辅助经导管主动脉瓣置换(TAVR)系统首次人体临床试验的首例患者治疗。手术由厦门大学附属心血管病医院的王焱教授及其团队完成,利用ReachTactile™机器人辅助TAVR系统为一名重度主动脉瓣狭窄患者植入TaurusElite®经导管主动脉瓣膜。ReachTactile是公司内部研发的机器人辅助TAVR系统,为TAVR治疗提供创新、高性价比的解决方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10